Remembering Wilko Johnson: A Pancreatic Cancer Story Unlike Most

The news

Wilko Johnson — the jerky, machine-gun rhythm guitarist of Dr. Feelgood, a founding influence on British punk, and later an actor on Game of Thrones — died at his home in England on November 21, 2022, at the age of 75. His family's announcement did not state a cause of death, and we won't speculate about one.

What Johnson did share, extraordinarily openly, was his cancer story. In early 2013 he announced he had been diagnosed with late-stage pancreatic cancer and told he had months to live. He declined chemotherapy, went on a farewell tour, and spoke about feeling vividly alive. Then the story turned: his tumor proved to be a rarer, more operable kind, and in 2014, after surgery to remove a very large tumor, he announced he was cancer-free. He lived nearly a decade beyond his original prognosis.

Why people are talking about it

Johnson's story is remembered because it holds two truths at once: pancreatic cancer is often found late and is genuinely serious, and yet a diagnosis is not always what it first appears. The difference in his case wasn't luck alone — it was the specific type of tumor he turned out to have.

What this cancer means

According to the National Cancer Institute, pancreatic cancer can develop from two kinds of cells in the pancreas. The exocrine type is far more common and is usually found at an advanced stage. Pancreatic neuroendocrine tumors — which form in the hormone-making islet cells of the pancreas — are much less common and, NCI notes, have a better prognosis.

Johnson publicly shared that his tumor was of this rarer neuroendocrine kind, which is why surgery became possible in his case. NCI explains that pancreatic neuroendocrine tumors can be benign or malignant, may grow more slowly, and are treated differently from the common exocrine form. Two people who both hear the words "pancreatic cancer" can be facing quite different diseases — a reminder of why the exact diagnosis, confirmed by pathology, matters so much.

Awareness, screening & prevention

Plain honesty: the National Cancer Institute states that it does not have evidence-based information on screening or prevention for pancreatic cancer. There is no routine screening test for it, and no proven prevention checklist. That can feel unsatisfying, but it's the accurate picture.

What is in most people's hands is staying current on the screenings that do exist for other cancers — our free screening check-up tool can show which screenings are generally recommended at your age — and bringing persistent, unexplained symptoms to a healthcare professional rather than waiting.

Common questions

Was Wilko Johnson "cured of pancreatic cancer"? He publicly announced being cancer-free after his 2014 surgery for a pancreatic neuroendocrine tumor — the rarer type NCI describes as having a better prognosis. His experience doesn't predict anyone else's, in either direction.

Why was his outcome so different from most pancreatic cancer stories? Type matters. NCI distinguishes the common exocrine form, usually found at an advanced stage, from neuroendocrine tumors, which behave differently. His doctors' revised diagnosis changed what was possible.

Is it wrong that he initially declined treatment? That was a personal choice he spoke about openly. Treatment decisions are individual, and the right place to weigh them is with a healthcare team, with an accurate diagnosis in hand.

Questions to ask a healthcare team

• If cancer is suspected, how will you confirm exactly what type it is?
• What would a second opinion on a pathology report involve?
• What symptoms related to digestion or the abdomen should I never ignore?
• How do treatment options differ between cancer types that share a name?